Clover Health is trading at $5.06, up 10.48%, after CMS awarded its PPO Medicare Advantage plans 5 Stars for 2027. - Its HMO plan received 4.5 Stars. - The PPO rating was calculated with 20 measures removed following a court decision that remains on appeal; coverage linked the ratings news to the shares’ sharp Friday premarket rise. - The quality ratings affect Medicare Advantage payments for 2028 and support year-round enrollment.